Cargando…
Memantine Disrupts Motor Coordination through Anxiety-like Behavior in CD1 Mice
Memantine is an FDA approved drug for the treatment of Alzheimer’s disease. It reduces neurodegeneration in the hippocampus and cerebral cortex through the inhibition of extrasynaptic NMDA receptors in patients and mouse models. Potentially, it could prevent neurodegeneration in other brain areas an...
Autores principales: | Shuvaev, Anton N., Belozor, Olga S., Mozhei, Oleg I., Mileiko, Aleksandra G., Mosina, Ludmila D., Laletina, Irina V., Mikhailov, Ilia G., Fritsler, Yana V., Shuvaev, Andrey N., Teschemacher, Anja G., Kasparov, Sergey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027563/ https://www.ncbi.nlm.nih.gov/pubmed/35448027 http://dx.doi.org/10.3390/brainsci12040495 |
Ejemplares similares
-
Protective Effect of Memantine on Bergmann Glia and Purkinje Cells Morphology in Optogenetic Model of Neurodegeneration in Mice
por: Shuvaev, Anton N., et al.
Publicado: (2021) -
Indirect Negative Effect of Mutant Ataxin-1 on Short- and Long-Term Synaptic Plasticity in Mouse Models of Spinocerebellar Ataxia Type 1
por: Shuvaev, Anton N., et al.
Publicado: (2022) -
Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
por: Mozhei, Oleg, et al.
Publicado: (2020) -
Extracellular S100β Disrupts Bergman Glia Morphology and Synaptic Transmission in Cerebellar Purkinje Cells
por: Belozor, Olga S., et al.
Publicado: (2019) -
Is L-lactate a novel signaling molecule in the brain?
por: Mosienko, Valentina, et al.
Publicado: (2015)